ストックスクリーナーアプリを入手
4.19
4.49%
0.18
前日終値:
$4.01
開ける：
$4.13
24時間の取引高:
1.45M
Relative Volume:
1.97
時価総額：
$271.82M
収益：
$207.32M
当期純損益:
$-61.04M
株価収益率:
-4.3751
EPS:
-0.9577
ネットキャッシュフロー:
$-25.97M
1週間 パフォーマンス:
+7.16%
1か月 パフォーマンス:
+52.36%
6か月 パフォーマンス:
+68.27%
1年 パフォーマンス:
-23.26%
1日の値動き範囲:
$4.05
$4.375
1週間の範囲:
$3.755
$4.469
52週間の値動き範囲:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
名前
Treace Medical Concepts Inc
セクター
電話
(904) 373-5940
住所
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.19 | 271.82M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-11-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-02-04 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-12-31 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 再開されました | JP Morgan | Neutral |
| 2024-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-08 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-08 | ダウングレード | Truist | Buy → Hold |
| 2023-09-29 | 開始されました | UBS | Buy |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2023-04-11 | 開始されました | Stephens | Equal-Weight |
| 2022-05-12 | 開始されました | BTIG Research | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 開始されました | JP Morgan | Overweight |
| 2021-05-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 開始されました | SVB Leerink | Outperform |
| 2021-05-18 | 開始されました | Stifel | Buy |
すべてを表示
Treace Medical Concepts Inc (TMCI) 最新ニュース
Treace Medical Concepts (TMCI) Q2 2024 earnings summary - Quartr
Treace Medical Concepts (TMCI) Q1 2026 earnings summary - Quartr
Treace Medical Concepts (TMCI) Proxy filing Summary - Quartr
Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary - Quartr
Treace treats its first patient with HyperPlate XM foot implant - Stock Titan
Treace Medical Concepts Inc - TradingKey
Treace Medical Concepts Inc (TMCI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Treace Medical Concepts Inc (TMCI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Treace Medical Concepts Inc (TMCI) Institutional Confidence - TradingKey
Treace Medical Concepts Inc (TMCI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Treace Medical Concepts Inc (TMCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Treace Medical Concepts Inc (TMCI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Treace Medical Concepts Balances Growth With Earnings Strain - TipRanks
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock - Investing.com UK
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock By Investing.com - Investing.com South Africa
Treace Medical (TMCI) CEO boosts direct stake with June share buys - Stock Titan
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock - Investing.com
Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases - Stock Titan
Treace to Present at the Sidoti Small Cap Conference - The Manila Times
Treace to showcase bunion surgery tech at Sidoti Small Cap Conference - Stock Titan
TMCI Q1 2026 Earnings: Narrowed Loss Beats Expectations Amidst Operational FocusEarnings Call Transcript - newsline.com
Treace Medical CEO John Treace buys $177,915 in company stock By Investing.com - Investing.com Nigeria
Treace Medical CEO John Treace buys $177,915 in company stock - Investing.com
Treace Medical (TMCI) CEO buys 50,000 shares in open-market trade - Stock Titan
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com Australia
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
William Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (TMCI) Declines 2.11% as Stock Nears Key Support at $2.64Covered Call ETF - The Legal Advocate
Treace Medical Concepts, Inc. 8-K SEC Filing Details and Company Information (May 19, 2026) - Minichart
Treace Medical Shareholders Back Directors, Pay and Auditor - TipRanks
Treace Medical Concepts shareholders elect directors and approve key proposals - Investing.com Australia
Treace Medical Concepts shareholders elect directors and approve key proposals By Investing.com - Investing.com South Africa
Treace Medical (TMCI) shareholders elect directors and ratify auditor at 2026 meeting - Stock Titan
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Treace Medical (TMCI) receives 30,000 restricted stock units - Stock Titan
Treace Medical (NASDAQ: TMCI) director gets 30,000 RSUs, holds 75,243 - Stock Titan
Armistice Capital (TMCI) discloses 6.36M shares, 9.85% stake - Stock Titan
Treace Medical Concepts Q1 earnings call highlights - MSN
Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing - Moomoo
Treace Medical Concepts CEO John Treace buys $375,505 in shares By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John Treace buys $375,505 in shares - Investing.com
TMCI (TMCI) CEO John Treace purchases over 150,000 company shares in open market - Stock Titan
Treace Medical Concepts Inc (TMCI) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
大文字化:
|
ボリューム (24 時間):